Tempest Therapeutics(TPST) - 2022 Q4 - Annual Report
Tempest Therapeutics(TPST)2023-03-22 21:29☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _______________________________________________________________________________________________________________________________ FORM 10-K _______________________________________________________________________________________________________________________________ (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO ...